Roche Holding | ROG - Market Capitalization


Roche Holding reported CHF279.47B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Alcon AG USD 28.74B 5.03B Nov/2026
Almirall EUR 2.3B 150.98M Nov/2026
Amgen USD 247.94B 20.06B Nov/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bayer EUR 52.42B 5.31B Nov/2026
Biogen USD 33.38B 1.48B Sep/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Fresenius EUR 28.97B 3.77B Nov/2026
Fresenius Medical Care EUR 12.06B 1.43B Nov/2026
Genmab DKK 17.1B 88.06B Jun/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
GRIFOLS EUR 4.76B 1.02B Nov/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.97B 239.87M Nov/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 64.74B 46.89B Nov/2026
Merck USD 375.59B 17.09B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Pfizer USD 165.12B 1.71B Nov/2026
Philips EUR 24.82B 3.69B Nov/2026
Recordati EUR 10.93B 82.06M Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
UCB EUR 46.41B 13.94B Dec/2025